European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, ...

Key players like Bayer AG and Fusion Pharmaceuticals are driving innovation in radioligand and alpha-particle therapies, addressing crucial market challenges such as radioisotope supply chain ...